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Results We found that carbohydrate (P < 0.001), 
total sugars (P < 0.001) and non-milk extrinsic sugars 
(P < 0.001) (% EI) were lower, whereas fat (P = 0.001) 
and protein (P = 0.038) intakes (% EI) were higher on the 
sugar-reduced than the regular diet. No effects on body 
weight, blood pressure, arterial stiffness, fasting glycemia 
or lipemia were observed.
Conclusions Consumption of sugar-reduced products, as 
part of a blinded dietary exchange for an 8-week period, 
resulted in a significant reduction in sugar intake. Body 
weight did not change significantly, which we propose was 
due to energy compensation.
Keywords Sugar · Sugar-reduced products · Obesity · 
Body weight · Dietary energy compensation · Artificial 
sweeteners
Introduction
There is much scientific debate regarding the potential 
impact of sugar consumption, especially in the form of 
sugar-sweetened beverages (SSB)5, on body weight sta-
tus and various cardiometabolic health outcomes [1–5]. 
Specific policies on reducing over-consumption of 
energy and prevention of obesity and its comorbidities 
often include a recommendation to reduce sugar intake, 
as a means of reducing overall calorie intake and assist-
ing with weight maintenance or prevention of weight 
gain [6, 7]. WHO guidelines recommend a population 
daily target for free sugars, namely ‘monosaccharides 
and disaccharides added to foods and beverages by the 
manufacturer, cook or consumer and the sugars naturally 
present in honey, syrups, fruit juices and fruit juice con-
centrates,’ of <10 % of total energy intake (% EI) [6]. A 
Abstract 
Purpose Consumption of sugar-reformulated products 
(commercially available foods and beverages that have been 
reduced in sugar content through reformulation) is a poten-
tial strategy for lowering sugar intake at a population level. 
The impact of sugar-reformulated products on body weight, 
energy balance (EB) dynamics and cardiovascular disease 
risk indicators has yet to be established. The REFORMu-
lated foods (REFORM) study examined the impact of an 
8-week sugar-reformulated product exchange on body 
weight, EB dynamics, blood pressure, arterial stiffness, gly-
cemia and lipemia.
Methods A randomized, controlled, double-blind, 
crossover dietary intervention study was performed with 
fifty healthy normal to overweight men and women (age 
32.0 ± 9.8 year, BMI 23.5 ± 3.0 kg/m2) who were ran-
domly assigned to consume either regular sugar or sugar-
reduced foods and beverages for 8 weeks, separated by 
4-week washout period. Body weight, energy intake (EI), 
energy expenditure and vascular markers were assessed at 
baseline and after both interventions.
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‘conditional’ recommendation for a limit of <5 % EI for 
free sugars was also suggested, as although the desirable 
effects of adherence to limiting free sugar intake to this 
value outweigh the undesirable effects to public health. 
Policy makers will require substantial debate with 
involvement of various stakeholders before translation to 
an unconditional recommendation [6].
Until recently, it was advised that the UK population 
average intake of ‘non-milk extrinsic sugars’ (NMES) 
should provide no more than 10 % EI [8]. Data from the 
UK National Diet and Nutrition Survey (NDNS) highlight 
that population targets are currently being exceeded, with 
the mean NMES intakes of 11.5 and 14.9 % EI in adults 
aged 19–64 year and children aged 4–18 year, respectively 
[9]. In 2015, the Scientific Advisory Committee on Nutri-
tion (SACN) recommended that the definition for ‘free sug-
ars’ be adopted in the UK and advised that the population 
average intake of these sugars should not exceed 5 % EI 
[10]. The only minor difference between free sugars and 
NMES is that the latter definition includes half of the quan-
tity of the sugars in stewed, dried or preserved fruit [11].
Consumption of commercially available sugar-reduced 
foods and beverages is seen as a potential strategy to 
lower sugar intake, and potentially EI [12]. Recently, the 
WHO have suggested that their 2015 guidelines on sugar 
intake should be used to develop a strategy for reformula-
tion of processed foods, such as those rich in free sugars 
[6]. However, it should be recognized that the replace-
ment of sugar-sweetened products with sugar-reduced or 
artificially sweetened alternatives may be associated with 
compensatory responses in EI and/or energy expenditure 
(EE), which in turn may only lead to modest weight loss 
[13–15]. Yet there are very limited data on the efficacy 
of using sugar-reformulated products on body weight, 
energy balance (EB) dynamics and the possibility of 
energy compensation [16].
The impact of sugar consumption on physiological 
markers of health is not fully established, but emerging 
evidence suggests that sugar consumption may be linked 
to lipid dysregulation, hypertension and inflammation [17, 
18]. In short-term human intervention studies, sucrose sup-
plementation has been shown to significantly increase total 
and low-density lipoprotein (LDL) cholesterol [19], as well 
as systolic and diastolic blood pressure (BP) [20] in over-
weight participants. However, more research is needed to 
examine the link between sugar consumption and novel and 
traditional markers of cardiometabolic health using a more 
physiologically relevant dietary model of sugar intake.
The reformulated foods (REFORM) study tested the 
hypothesis that, if energy compensation does not occur, 
reducing NMES intake to ≤10 % EI by exchanging refor-
mulated, sugar-reduced foods and beverages for habitually 
consumed products would result in weight loss compared 
with matched regular products and that this would impact 
on markers of vascular health, glycemia and lipemia in 
healthy normal to overweight men and women. Indeed, 
preventative public health strategies that target healthy 
populations by addressing behavioral risk factors such as 
unhealthy dietary practices, including the high consump-
tion of dietary sugars, could be effective approaches for 
promoting health and preventing cardiometabolic disease 
progression [21].
Experimental methods
Participants
The REFORM study included men (n = 16) and women 
(n = 34) aged 20–49 year who were not underweight 
or obese (BMI between 18.5 and 30 kg/m2) who were 
recruited from the local community of Reading, UK, in 
one cohort between March and September 2012. The 
intervention visits ran between May 2012 and March 
2013. Recruitment strategies included targeted mail-
ings to volunteers on local participant databases. Post-
ers and flyers were circulated around the university 
campus as well as social and community groups in the 
Reading area. Key exclusion criteria were as follows: 
clinical diagnosis of diabetes, CVD, anti-inflammatory 
or hypertensive medication, smoking, excessive alcohol 
consumption (>21 units per week for men and >14 units 
per week for women), participation in regular vigorous 
exercise or fitness training (≥20 min × 3 times/week), 
pregnancy or lactating. The Joint British Societies’ JBS-2 
total CVD risk calculator was used to estimate the prob-
ability (percentage chance) that a participant would expe-
rience a CVD event over the next 10-year period [22]. 
Dietary restraint was quantified using the Three-Factor 
Eating Questionnaire, with a score >11 (Factor I) indi-
cating restrained eating [23, 24]; this score was used to 
characterize the cohort, but it was not used as an exclu-
sion criteria for study participation.
Participants were not aware that the primary outcome of 
the study was body weight, as this could have influenced 
the study outcome. They were told that the purpose of the 
study was to examine the effect of reformulated fat, salt or 
sugar-reduced beverage and food items on risk factors for 
CVD. All procedures involving human participants were 
approved by the University of Reading’s Research Ethics 
Committee (12/03). Written informed consent was obtained 
from all participants before participation. The REFORM 
study was registered a clinical trial (Clinicaltrials.Gov ID: 
NCT01645995).
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Study design
The REFORM study was performed using a randomized, 
controlled, double-blind, crossover design and consisted 
of two 8-week dietary exchange intervention periods. Par-
ticipants attended the Hugh Sinclair Unit of Human Nutri-
tion on four separate occasions (before and after the two 
intervention phases). A computer-based minimization pro-
cedure (minimized on age, gender, BMI) was used to ran-
domly allocate participants to consume either regular or 
sugar-reduced products (i.e., diet A or diet B) during their 
first 8-week dietary exchange period [25]. This was subse-
quently followed by a 4-week washout period after which 
the participants began the alternate study intervention.
Participants were advised prior to each visit to avoid 
strenuous physical activity (PA) and alcohol consumption 
for a 24-h period. Following a standardized low-fat evening 
meal (<400 kcal; <9 g fat), participants completed a 12-h 
fast.
Dietary exchange model
For the REFORM dietary intervention, a flexible food 
exchange model, based on average UK food intake data of 
adults aged 19–64 year, was developed using a well-estab-
lished approach that allows for minimal disruption to the 
habitual diet of free-living individuals [26]. The amount 
of exchangeable sugar in the free-living UK diet was 
Table 1  REFORM food exchange model: removal of major exchangeable sources of dietary sugar in the UK diet and replacement of exchange-
able sugar with REFORM study beverages and foods
CHO carbohydrate, NMES non-milk extrinsic sugars
a  Based on National Diet and Nutrition Survey (NDNS), 2003 for adults (19–64 year) [27]
b  Quantity varied depending on the study beverage or food. The replacement model was based on 1 beverage and 1 food per day and excluded 
ad libitum intake of condiments
Mean quantity (g/day) Energy (kcal/day) CHO (g/day) Total sugars (g/day) NMES (g/day) Starch (g/day)
NDNS intakea 1918 227.0 99.3 62.1 127.8
Exchangeable sugar intake
Breakfast cereals 19 47 7.8 3.7 1.5 5.3
Puddings 12 19 2.3 1.5 1.3 0.4
Vegetables (baked beans) 93 42 9.1 3.4 1.5 4.6
Sugar, preserves and confection-
ary
24 100 15.9 18.2 13.9 0.0
Yoghurts, ice cream and other 
milks
38 58 4.5 3.0 2.4 0.3
Soft drinks and fruit juice 199 46 15.9 17.4 15.2 0.0
Savory sauces and condiments 22 38 2.3 4.7 1.5 3.0
Total exchangeable sugar intake 350 57.8 51.9 37.3 13.6
NDNS intake—total exchange-
able sugar (Non-modifiable 
sugar intake)
1568 169 47.4 24.8 114.2
Regular dietary exchange
Study beverage (mean of seven 
choices)b
315 160 37.7 37.6 37.7 0.1
Study food (mean of fifteen 
choices)b
74 107 18.5 14.7 12.6 3.8
Total intake 389 1835 225.2 99.7 75.1 118.1
Reformulated dietary exchange
Study beverage (mean of seven 
choices)b
315 17 2.0 1.9 1.9 0.0
Study food (mean of fifteen 
choices)b
73 75 11.7 3.1 2.2 4.6
Total intake 388 1660 182.7 52.4 28.9 118.8
Mean difference between dietary 
exchanges
175 42.5 47.3 46.2 −0.7
 Eur J Nutr
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calculated from the NDNS database [27] as the total NMES 
present in the following easily accessible food sources: 
breakfast cereals, baked beans, puddings, chocolate, sweet 
confectionary, sweet spreads, savory sauces, condiments, 
soft drinks, fruit juice, yoghurt, ice cream and other milks 
(Table 1). It was estimated that 60 % of the sugar-contain-
ing processed foods and beverages could be exchanged 
so as to manipulate the overall NMES composition of the 
habitual diet. Commercially available regular and sugar-
reduced products, with a specific NMES profile, were 
tested in the dietary exchange model; it was quantified that 
the minimum daily NMES difference between the regular 
and reformulated dietary exchange periods was 32 g/day, 
with the reformulated arm consuming <7 % EI as NMES.
Dietary exchange intervention and compliance 
monitoring
For each 8-week dietary exchange period, participants 
exchanged ≥1 beverage and ≥1 food portion per day from 
their habitual diet with equivalent sugar-containing or 
sugar-reformulated products (for details of study foods, see 
Online Resource 1). After completing baseline study visits 
(at the beginning of each dietary assessment period), par-
ticipants were given personalized advice about the dietary 
exchange intervention and how to incorporate the study 
products into their diet. Participants were given adequate 
study product supplies for a 4-week period at the beginning 
of each dietary assessment period. They also attended the 
Hugh Sinclair Unit of Human Nutrition for a food collec-
tion visit and dietary compliance assessment at week 4, the 
midway point in each dietary exchange period. During this 
visit, completed compliance sheets were assessed and any 
issues with dietary adherence were addressed and recti-
fied. To encourage dietary adherence and reduce the likeli-
hood of ‘product boredom’ [26], participants were provided 
with sufficient study products from a choice of 7 beverages 
including juice drinks and soft drinks, and 19 foods, includ-
ing pasta sauce, baked beans, muesli, puddings and sweet 
confectionary (for details, see Online Resource 1). Partici-
pants were asked to replace habitually used sugar and con-
diments with those provided by the investigators ad libitum 
throughout the dietary exchange periods (Online Resource 
1). Study product selection was based on each participants’ 
response to a food preference screening list that itemized 
the beverage, food, sugar and condiments options that 
were available to them as part of the dietary exchange 
intervention. They were asked to consume similar types of 
REFORM beverages/foods during their second arm of the 
study so that the regular and reformulated product types 
would be matched. Participants completed a daily dietary 
compliance sheet to assess their intake of the study prod-
ucts during the two 8-week dietary assessment periods (i.e., 
for a 56-day period). At the end of the first diet period, par-
ticipants were asked to return unopened leftover products 
to the Nutrition Unit. They were instructed not to consume 
leftover study products during their washout period and 
were advised to return to their habitual diet.
Study products were presented to volunteers in a 
blinded manner. An investigator not involved with assess-
ing study outcomes de-branded, relabeled or repackaged 
the study products so that they appeared identical between 
interventions, with the two dietary exchange products 
identifiable by diet A or B. The minimum beverage or food 
portion size was stated by weight and in general household 
measures.
Assessment of intervention foods and blinding strategy
At the end of each 8-week dietary period, the study prod-
ucts were assessed for visual appeal, smell, taste, aftertaste 
and palatability using visual analogue scale (VAS) ques-
tionnaires [28]. Each VAS assessed a sensation on a 100-
mm horizontal line, anchored at the beginning and end by 
opposing statements. On completion of the study, a retro-
spective questionnaire assessed participants’ perceived 
awareness of the order in which they had been assigned to 
the regular and reformulated study products.
Assessment of dietary intake
Four-day weighed food diaries were completed prior to 
commencing and during the final week of the dietary 
exchange periods (week 0, 8, 12, 20). Participants com-
pleted their food diaries over three weekdays and one 
weekend day, with the same days repeated for subsequent 
food diaries. Detailed verbal and written instructions for 
completing their 4-day weighed food diaries were given 
to participants ≥7 days prior to their first study visit. A set 
of sample diaries and a set of digital scales were also pro-
vided, and the importance of not changing habitual dietary 
patterns was emphasized. Participants were asked to record 
recipes used during cooking and retain packaging from 
ready meals so that the items could be added to the dietary 
database. During study visits, food diaries were assessed 
for completeness. If necessary, further detail was collected 
to facilitate precise data entry.
Dietplan software (version 6.60; Forestfield Software 
Ltd.) was used to calculate specific energy and macronu-
trient intake. The nutrient composition of foods consumed 
was based on NDS Nutrient Database or McCance and 
Widdowson’s food tables. Dietary fiber intake was defined 
as non-starch polysaccharide (NSP) using the technique of 
Englyst and Cummings [29]. The composition of the study 
products was also added to Dietplan, based on manufac-
turer details.
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Assessment of physical activity
Participants were instructed to wear a triaxial accelerom-
eter (GT3X + activity monitor; Actigraph, LLC) directly 
above the right iliac crest during sleeping and waking hours 
(except during water-based activities) for seven consecu-
tive days, over the same time period that dietary intake was 
assessed. Device initialization, data processing and analy-
sis were conducted using Actilife data analysis software 
(version 6.4.5). For analysis inclusion, participants were 
required to have produced counts on their activity monitor 
for ≥4 days (>600 min/day of wear time) [30]. Non-wear 
time was defined as ≥60 min of zero activity counts [31]. 
Data were summarized in 60-sec epochs, and mean EE 
from PA (EEPA) was calculated (kcal/day). Total daily step 
count, based on accelerometry, was also calculated and was 
used to estimate PA levels with <5000, 5000–7400, 7500–
9999 and 10,000 steps/day categorizing participants as sed-
entary, low active, somewhat active and active, respectively 
[32, 33].
Basal metabolic rate
Basal metabolic rate (BMR) for each participant was cal-
culated based on age, gender and body weight using the 
Henry equation [34].
Body weight
Upon arrival at the Nutrition Unit, height was measured to 
the nearest 0.1 cm using a wall-mounted stadiometer (first 
visit only). While wearing light garments, body mass (kg) 
and body fat (%) were assessed by Tanita Body Composi-
tion Analyzer (BC-418 MA; Ill, USA) using standard set-
tings (normal adult body type and 1 kg for clothing) at 
week 0, 8, 12 and 20.
Blood pressure and arterial stiffness
Participants rested semi-recumbent in a temperature-con-
trolled vascular suite (22 ± 1 °C). After a 20-min rest and 
familiarization period, BP was recorded in triplicate using 
an ambulatory upper arm BP monitor (ABPM TM-243; 
A&D Instruments Ltd.). Digital volume pulse (DVP) and 
pulse wave analysis (PWA) were assessed as markers of 
vascular stiffness. DVP was determined by placing a photo-
plethysmographic transducer on the left index finger (Pulse 
Trace PCA 2 device; Micro Medical Ltd.). Measurements 
were taken in triplicate for calculation of mean reflection 
index (DVP–RI) and stiffness index (DVP–SI) [35]. PWA 
was carried out by a single trained operator using the 
SphygmoCor (ScanMed Medical; see [36] for details). The 
pulse pressure wave at the radial artery was recorded using 
applanation tonometry [37]. The mean of two values with 
the highest operator index (≥80) was averaged to calculate 
the augmentation index (AIx), a measure of overall sys-
temic arterial stiffness and AIx adjusted to a standard HR 
of 75 bpm (AIx HR75).
Blood sampling and biochemical analysis
Venous blood samples were collected and centrifuged at 
3000 rpm for 15 min at 4 °C. Serum and plasma were 
separated and stored at −80 °C until subsequent analy-
sis. Concentrations of serum lipids [total cholesterol, 
high-density lipoprotein cholesterol and triacylglyc-
erol (TAG)], C-reactive protein, non-esterified fatty acid 
and glucose were determined using enzyme-based col-
orimetric tests on an ILab 600 Clinical Chemistry Ana-
lyzer (Instrumentation Laboratories Ltd.). The ratio of 
total:HDL cholesterol was calculated. LDL cholesterol 
concentrations were measured according to the Friede-
wald equation [38]. Plasma insulin concentrations were 
determined with enzyme immunoassay kits (Alere Ltd.). 
Samples from each participant were analyzed in a single 
run to minimize inter-batch variation.
Energy intake and body weight simulation tool
For each participant, baseline variables including height, 
weight, age and gender were entered into the NIDDK 
human body weight simulation tool [16]. PA level, pre-
dicted from mean daily step count categories which were 
coded to match corresponding activity levels 1.4, 1.5, 1.6 
and 1.9 in model [16, 33], was also entered. Collectively, 
these variables were used to provide a prediction of base-
line EI (kcal/day).
For the body weight simulation, it was a required 
assumption that the PA level remained constant for the 
duration of each dietary exchange period. For body weight 
simulation, the value of 181 kcal/day was chosen to repre-
sent the mean energy deficit of the group during the refor-
mulated dietary exchange period. This was calculated from 
the average of each participant’s 56-day caloric difference 
between the regular and reformulated dietary exchange 
periods (Online Resource 2). The energy deficit value 
was subtracted from the predicted baseline EI and pre-
dicted weight, after a 56-day body weight simulation was 
recorded. For body weight simulation following the regular 
dietary exchange period, it was assumed that EI remained 
constant, i.e., the same as that predicted at baseline.
Power calculation
Power calculations were based on body weight, our pri-
mary outcome measure. An estimated weight loss of 1.2 kg 
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was predicted with a daily conservative target difference of 
181 kcal/day between the regular and reformulated dietary 
exchange phases for an 8-week period. The SD of weight 
reduction was estimated as 1.1 kg. Based on a previous 
calculation [39], an estimated recruitment of n = 37 par-
ticipants was deemed necessary to give sufficient power to 
detect significant changes in our secondary outcome meas-
ures including biochemical analysis, if energy compensa-
tion did not occur, with P < 0.05 and 80 % power. With the 
allowance for a 25 % dropout rate, we aimed to recruit a 
minimum of 47 participants.
Statistical analysis
All statistical analysis was performed on primary (body 
weight) and secondary outcome measures using SPSS (ver-
sion 19.0; SPSS Inc.). Data that were not normally distrib-
uted, as assessed by the Shapiro–Wilk test, were logarithmi-
cally transformed. The potential impact of an intervention 
order was assessed by adding it as a main effect to our 
repeated measures ANOVA model. However, because no 
significant interactions between intervention order and our 
other main effects (time and diet) were detected, a two-way 
Fig. 1  Flow of participants through the different stages of the REFORM study
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ANOVA was used to identify significant time X diet (T X D) 
interactions. Bonferroni post hoc corrections were applied 
to all data to control for multiple comparisons. For our pri-
mary outcome measure, multiple adjustments were made for 
age, gender and dietary restraint using a two-way ANCOVA. 
The association between observed and predicted (using the 
body weight simulation model [33]) body weights was ana-
lyzed using Pearson’s correlations. Paired t tests were used 
to compare dietary compliance data. Differences in baseline 
characteristics between participants randomly assigned to 
the regular and reformulated dietary exchange arms were 
assessed by using the independent t tests and the Chi square 
test for continuous and categorical variables, respectively 
(Online Resource 3). Data are presented as mean ± SD. P 
values < 0.05 were deemed to be significant.
Results
Participants
Participant flow through the study is illustrated in Fig. 1. 
In total, 87 individuals were screened; 56 were recruited to 
the study and 50 participants (n = 40 White; n = 9 Asian; 
n = 1 Black) completed all four study visits. Both dietary 
exchange periods were well tolerated by participants, and 
no adverse events were reported. The baseline character-
istics of the participants are highlighted in Table 2. Over-
all, participants had a 1.8 ± 3.4 % chance of developing 
CVD risk over the next 10-year period using the JBS-2 
total CVD risk calculator [22]. Mean dietary restraint 
scores were 6.6 ± 4.2, with nine participants identified as 
restrained eaters. Five participants were excluded from the 
EI and EEPA analysis due to insufficient data.
Energy and macronutrient intake
Mean habitual diets reported by the participants at baseline 
were comparable to representative dietary values for UK 
adults [9]. NMES intake fell to a mean of 8.3 % EI, meeting 
the criteria of ≤10 % EI on the sugar-reformulated diet. As 
a % EI, carbohydrate (P < 0.001), total sugars (P < 0.001) 
and NMES (P < 0.001) were lower, whereas fat (P = 0.001) 
and protein (P = 0.038) were higher on the sugar-reduced 
diet compared with the regular diet (Table 3).
Body weight and energy balance dynamics
There was no significant interaction for our primary out-
come measure, body weight or percentage body fat, or for 
EI, EEPA or EEBMR (Table 4). Further analysis revealed 
that there was no significant impact of the interven-
tion on body weight when it was adjusted for multiple 
covariates including age, gender and dietary restraint 
(time: P = 0.556; diet: P = 0.312; time x diet interaction: 
P = 0.203).
Energy intake and body weight prediction model
Using the NIDDK mathematical model [16], predicted 
EI at baseline and post-intervention was calculated. The 
baseline predicted EI did not differ significantly between 
the regular and reformulated dietary exchange periods 
(Regular 2420 ± 385; Reformulated 2410 ± 389 kcal/
day; P = 0.443). A mean of 79.2 and 80.8 % of predicted 
EI was reported from dietary analysis by participants 
prior to the regular and reformulated dietary exchange 
periods, but there was no significant difference in the 
baseline levels of under-reporting between the two die-
tary periods (P = 0.786). We observed a significant asso-
ciation between the predicted and observed body weight 
following the regular (r = 0.993, P < 0.001) and refor-
mulated dietary exchange periods (r = 0.994, P < 0.001). 
The arithmetic difference between the predicted and 
Table 2  Baseline characteristics of 50 participants who completed 
the interventiona
BMI body mass index, EEPA energy expenditure from physical activ-
ity assessed by triaxial accelerometry, EI energy intake, HDL high-
density lipoprotein, LDL low-density lipoprotein
a  Values are presented as mean ± SD
b  n = 48
c  n = 45
Parameter
Gender [n (%)]
M 16 (32)
F 34 (68)
Age (year) 31.6 ± 9.5
Body weight (kg) 69.8 ± 11.4
BMI (kg/m2) 24.0 ± 3.3
Body fat (%) 27.0 ± 9.6
Supine systolic blood pressure (mmHg) 116 ± 11
Supine diastolic blood pressure (mmHg) 71 ± 8
Glucose (mmol/L) 4.85 ± 0.42
Insulin (pmol/L)b 31.0 ± 14.3
Total cholesterol (mmol/L) 4.63 ± 0.71
HDL cholesterol (mmol/L) 1.50 ± 0.37
Total: HDL cholesterol ratio 3.22 ± 0.77
LDL cholesterol (mmol/L) 2.71 ± 0.61
Triacylglycerol (mmol/L) 0.93 ± 0.39
EI (kcal/day)c 2078 ± 675
EEPA (kcal/day)
c 446 ± 157
Mean accelerometer wear time (min/day) 1187 ± 128
Number of steps (counts/day)c 9064 ± 2615
 Eur J Nutr
1 3
observed body weight differed significantly following the 
8-week regular and reformulated dietary exchange peri-
ods (Regular 0.9 ± 1.3 kg; Reformulated −1.5 ± 1.2 kg; 
P < 0.001).
Blood pressure and arterial stiffness
There were no significant differences in systolic or diastolic 
BP between treatments (Table 5). Furthermore, no signifi-
cant interactions were observed for DVP-SI, DVP-RI, AIx 
or AIx HR75 (Table 5).
Biochemical parameters
There were no significant changes in biochemical param-
eters following the regular compared with the reformulated 
products (Table 5).
Assessment of dietary compliance, intervention foods 
and blinding strategy
The mean caloric and NMES differences between the reg-
ular and reformulated dietary exchange periods, inclusive 
of sugar and condiments, that were calculated for the two 
complete 8-week dietary assessment periods were 181 kcal/
day and 54.4 g/day, respectively (see Online Resource 3 for 
dietary compliance data) with significantly higher intakes 
Table 3  Daily energy and macronutrient intake at baseline (pre-) and 
during week-7 (post-) of the regular or reformulated dietary exchange 
perioda,b
CHO carbohydrate, D diet, EI energy intake, NMES non-milk extrin-
sic sugars, T time, TXD time X diet
a  Values are presented as mean ± SD
b  n = 45
c  Data were log transformed
Regular Reformulated P values
T D TXD
EI (kcal/day) 0.201 0.208 0.075
Pre- 1895 ± 568 1916 ± 553
Post- 2049 ± 529 1887 ± 546
Protein (% EI)c 0.383 <0.001 0.038
Pre- 16.4 ± 3.8 16.3 ± 3.8
Post- 14.3 ± 2.6 15.4 ± 3.2
Fat (% EI) 0.180 0.003 0.001
Pre- 33.9 ± 5.4 32.3 ± 6.5
Post- 29.6 ± 6.1 32.8 ± 6.3
CHO (% EI) 0.007 <0.001 <0.001
Pre- 47.3 ± 6.7 49.2 ± 6.9
Post- 54.2 ± 7.3 48.2 ± 7.8
Total sugars 
(% EI)c
0.000 0.314 <0.001
Pre- 20.6 ± 6.6 21.8 ± 7.3
Post- 28.0 ± 7.0 17.1 ± 6.1
Starch (% EI) 0.871 0.400 0.786
Pre- 25.6 ± 6.3 25.8 ± 6.2
Post- 24.6 ± 5.6 27.1 ± 7.1
NMES (% EI) <0.001 0.003 <0.001
Pre- 10.5 ± 5.0 11.0 ± 6.2
Post- 19.7 ± 5.6 8.3 ± 4.7
Fiber intake (g/
day)c
0.512 0.005 0.638
Pre- 15.0 ± 6.9 14.9 ± 6.5
Post- 16.1 ± 6.1 16.6 ± 5.6
Table 4  Energy balance dynamics and body composition at baseline 
(pre-) and at 8 weeks (post-) after random assignment to a regular or 
reformulated dietary exchange perioda,b
BMI body mass index, D diet, EEBMR energy expenditure by basal 
metabolic rate, EI energy intake, EEPA energy expenditure from phys-
ical activity assessed by triaxial accelerometry, T time, TXD time X 
diet
a  Values are presented as mean ± SD
b  n = 45
c  n = 50
d  Data were log transformed
e  Estimated with an equation including age, gender and body weight 
[34]
Regular Reformulated P values
T D TXD
EI (kcal/day) 0.201 0.208 0.075
Pre- 1895 ± 568 1916 ± 553
Post- 2049 ± 529 1887 ± 546
EEPA (kcal/day) 0.738 0.014 0.970
Pre- 432 ± 166 436 ± 169
Post- 419 ± 201 405 ± 149
EEBMR (kcal/day)
e 0.666 0.136 0.631
Pre- 1483 ± 206 1479 ± 210
Post- 1489 ± 204 1489 ± 206
Weight (kg)c 0.448 0.035 0.251
Pre- 69.8 ± 11.5 70.1 ± 11.3
Post- 70.3 ± 11.3 70.2 ± 11.4
BMI (kg/m2)c,d 0.300 0.401 0.202
Pre- 24.0 ± 3.4 24.1 ± 3.3
Post- 24.1 ± 3.3 24.1 ± 3.4
Body fat (%)c 0.222 0.447 0.541
Pre- 26.9 ± 9.6 27.2 ± 9.4
Post- 27.1 ± 9.2 27.3 ± 9.4
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Table 5  Blood pressure, 
arterial stiffness measurements 
and biochemical parameters at 
baseline (pre-) and at 8 weeks 
(post) after random assignment 
to a regular or reformulated 
dietary exchange perioda,b
P values
Parameter Regular Reformulated T D TXD
Supine systolic blood pressure (mmHg)e 0.813 0.188 0.518
Pre- 116 ± 11 116 ± 12
Post- 116 ± 11 115 ± 12
Supine diastolic blood pressure (mmHg) 0.113 0.970 0.844
Pre- 71 ± 7 72 ± 8
Post- 71 ± 8 72 ± 8
Digital volume pulse stiffness index (m/s)c 0.416 0.099 0.477
Pre- 5.5 ± 0.7 5.5 ± 0.6
Post- 5.5 ± 0.6 5.6 ± 0.7
Digital volume pulse reflection index (%)c 0.477 0.132 0.752
Pre- 55.5 ± 12.1 56.6 ± 11.6
Post- 57.7 ± 10.7 58.1 ± 13.2
Pulse wave analysis augmentation index (%)e 0.198 0.259 0.234
Pre- 13.9 ± 11.6 14.2 ± 13.1
Post- 14.2 ± 11.7 15.1 ± 13.4
Pulse wave analysis augmentation index adjusted to a 
standard HR of 75 bpm (%)
0.442 0.400 0.736
Pre- 6.3 ± 12.1 5.2 ± 14.2
Post- 6.8 ± 12.3 7.3 ± 13.8
Glucose (mmol/L) 0.611 0.010 0.220
Pre- 4.86 ± 0.40 4.84 ± 0.42
Post- 4.90 ± 0.45 4.95 ± 0.39
Insulin (pmol/L)d,e 0.185 0.072 0.665
Pre- 34.9 ± 20.4 33.6 ± 18.9
Post- 37.6 ± 20.5 35.2 ± 20.4
Total cholesterol (mmol/L)e 0.653 0.352 0.021
Pre- 4.67 ± 0.70 4.57 ± 0.69
Post- 4.59 ± 0.65 4.58 ± 0.67
HDL cholesterol (mmol/L)e 0.359 0.500 0.067
Pre- 1.54 ± 0.38 1.50 ± 0.37
Post- 1.51 ± 0.38 1.51 ± 0.34
Total:HDL cholesterol ratioe 0.672 0.993 0.457
Pre- 3.17 ± 0.76 3.17 ± 0.74
Post- 3.18 ± 0.76 3.14 ± 0.70
LDL cholesterol (mmol/L)e 0.338 0.387 0.360
Pre- 2.74 ± 0.61 2.66 ± 0.58
Post- 2.67 ± 0.55 2.66 ± 0.56
Triacylglycerol (mmol/L)e 0.954 0.460 0.419
Pre- 0.88 ± 0.37 0.90 ± 0.37
Post- 0.92 ± 0.38 0.91 ± 0.41
Non-esterified fatty acid (μmol/L)e 0.704 0.044 0.898
Pre- 464.5 ± 164.3 473.9 ± 176.2
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of NMES after the regular (Pre- 52.4 ± 35.8 g/day, Post- 
98.9 ± 34.0 g/day), when compared with the reformu-
lated arm (Pre- 54.3 ± 36.4 g/day, Post- 37.8 ± 19.9 g/
day; P < 0.001). These values were higher than our target 
difference in NMES intake as calculated using the dietary 
exchange model (Table 1) and provide evidence that the 
dietary objectives of REFORM were successfully met and 
exceeded.
Lower mean ratings of taste (23.0 ± 10.8 vs 
28.9 ± 11.6 mm; P < 0.001) and palatability (23.7 ± 11.2 
vs 28.2 ± 12.5 mm; P = 0.009) of the reformulated com-
pared with the regular products were observed. Visual 
appeal, smell and aftertaste of the products did not vary 
significantly between treatments (data not shown). A total 
of 83 % of all participants correctly identified the regular 
and reformulated products.
Discussion
The REFORM randomized controlled trial is the first to 
examine the impact of sugar-reformulated food and bever-
age consumption on the dynamics of body weight, EB, BP, 
arterial stiffness, serum glucose and lipid concentrations in 
normal to overweight free-living adults [BMI mean (range) 
23.5 (18.4–29.9) kg/m2] in a suitably powered study. We 
observed that when sugar-reduced foods and beverages 
were consumed as part of the habitual diet no significant 
change in body weight was observed. This was due to 
energy compensation; fat and protein intakes were both 
higher on the sugar-reduced diet, when compared to the 
regular diet.
Our cohort was relatively healthy with a generally 
low risk of developing CVD [22], yet they exceeded UK 
Department of Health dietary recommendations [8] by con-
suming >10 % EI from NMES at baseline. A strength of 
the REFORM study was the successful implementation of 
the novel dietary exchange model, resulting in the reduc-
tion in dietary targets of NMES, in line with recommen-
dations [8] using both foods and beverages as intervention 
products. It is relatively simple to reduce the energy con-
tent of beverages by directly exchanging sugars with arti-
ficial sweeteners (AS). However, in more complex matri-
ces, such as some of the reformulated foods used in our 
intervention, replacement of sugars with other nutrients 
such as starch is required to maintain functional proper-
ties of the products, and this may result in a smaller reduc-
tion in energy content [40]. Due to the inherent challenges 
of using sugar-reformulated foods in dietary intervention 
studies, their efficacy is poorly studied. Yet it is fundamen-
tal to determine their value as a strategy to reduce dietary 
sugar and energy for long-term weight control [12]. Spe-
cific dietary targets during the exchange periods of our 
intervention were largely achieved. Using the NIDDK sim-
ulation tool [16], body weight was predicted to be lower 
than observed, between the reformulated and regular die-
tary exchange periods, with no change in EEPA and EEBMR, 
supporting our hypothesis of dietary energy compensation. 
Although the change did not reach statistical significance, 
EI was lower following the reformulated diet period, and 
this was matched by lower PA-related EE, suggesting that 
this may have also contributed to the observed energy com-
pensation. Our study was limited by the fact that we did 
not use a calorimetric method for determination of EE [41, 
42]; therefore, it is possible that small changes in total EE 
may have also contributed to energy compensation. During 
the regular arm of the study, it should be noted that par-
ticipants increased their intake of NMES to 20 % EI, a 9 % 
increase when compared to baseline. In line with this, the 
studies of Reid and colleagues highlighted that, regardless 
of level of adiposity, when given in a blinded manner to 
free-living women for a 4-week period, SSB supplementa-
tion (4 × 250 mL; 430 kcal/day) was partially compensated 
for through voluntary reductions in macronutrient intake 
P values
Parameter Regular Reformulated T D TXD
Post- 443.3 ± 189.7 436.5 ± 170.4
C-reactive protein (mg/L)e 0.547 0.581 0.593
Pre- 0.93 ± 0.94 1.05 ± 1.35
Post- 0.99 ± 1.03 1.21 ± 1.50
D diet, HDL high-density lipoprotein, LDL low-density lipoprotein, T time, T X D time X diet
a  Values are presented as mean ± SD
b  n = 50
c  n = 47
d  n = 48
e  Data were log transformed
Table 5  continued
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and hence did not lead to weight gain [33, 43, 44]. Follow-
ing a 6-month intervention where overweight individuals 
were randomly assigned to consume either 1000 mL/day 
of sugar-sweetened cola, diet cola, semi-skimmed milk or 
water, Maersk et al. [45] did show that regular cola intake 
significantly enhanced fat accumulation in the liver, skel-
etal muscle and visceral fat, with no overall change in total 
fat or body weight. An increased production of plasma TAG 
was proposed as one plausible mechanism for the body 
weight-independent metabolic effect of dietary sugar [45]. 
Although we did not measure specific organ fat accumula-
tion in the present study, it seems unlikely that we would 
have observed any changes in this parameter, given the lack 
of effect on circulating serum TAG.
Consumption of the sugar-reformulated products, in 
exchange for regular matched products in the REFORM 
study, did not result in differences in fasting BP, arte-
rial stiffness, glycemia or lipemia. Despite not finding an 
impact of a 6-week high sucrose diet (25 % EI) on BP, 
PWA or any metabolic variable, Black and colleagues [19] 
observed modest increases in total and LDL cholesterol. In 
addition, during a 10-week sucrose supplementation period 
(~2 g/kg of body weight), where supplements were mostly 
given in the form of SSBs, Raben et al. [20] found a sig-
nificant increase in systolic or diastolic BP compared to a 
diet rich in AS, while a more recent paper by this group 
showed that no independent effects on fasting insulin and 
postprandial TAG concentrations were observed, when data 
were adjusted for body weight change [46].
Although potential underlying mechanisms responsi-
ble for the relationship between added sugar consumption 
and cardiometabolic risk are not fully established, emerg-
ing research suggests that in addition to the indirect impact 
of weight gain on these parameters, excessive added sugar 
consumption may impact on several physiological path-
ways [47, 48]. When consumed in excess (>20 % EI), 
fructose intake has been adversely linked to de novo lipo-
genesis, BP, visceral and ectopic fat deposition, insulin 
sensitivity as well as fat oxidation [18, 45, 49], although 
these levels far exceed current intakes. Furthermore, men 
and women with a genetic predisposition to obesity had a 
more pronounced susceptibility to the impact of SSBs on 
adiposity [50]. Future investigation is necessary to evalu-
ate the differential impact of ethnicity on adiposity and car-
diometabolic risk markers in response to regular sugar and 
sugar-reduced product consumption.
There are possible limitations of the REFORM study. 
Although sufficiently powered to detect predicted weight 
changes associated with the energy deficit if EB was 
maintained, our intervention period may not have been 
adequate to identify changes in some secondary outcome 
measures, including arterial stiffness [51]. Additionally, 
our dietary exchange provided a realistic dietary sugar 
intake from consumption of commercially available sugar-
reformulated foods and beverages, but this resulted in 
modest differences in sugar intake compared with other 
studies [18, 20, 33, 43, 44]. Despite this, the body simu-
lation tool [16] predicted that these modest differences 
in dietary sugar intake were sufficient to detect a differ-
ence of 2.4 ± 1.7 kg in body weight between the diets. 
This was not observed and indicates partial compensa-
tion for the lower or higher EI during the reformulated or 
regular dietary arm, respectively, confirming our dietary 
intake data. We also acknowledge the limitation of esti-
mating EI using self-reported measurements [41], but note 
that this issue was deemed to be less significant, given that 
we supplied the regular and sugar-reduced study foods for 
the participants to consume during their dietary exchange 
periods and monitored dietary compliance. Furthermore, 
mean EI predicted by the NIDDK model [33] did not dif-
fer between the regular and reformulated dietary exchange 
periods at baseline.
Evaluation of the efficacy of public health strategies for 
health promotion is essential. Previous food reformulation 
strategies targeting salt and trans fatty acid reduction have 
proven effective [7, 52], while the success of sugar-refor-
mulated products is less clear. Systematic reduction in the 
sugar content of food stuffs, without any AS substitution, 
may be a feasible approach to reducing sugar consumption 
and re-educating the palate to accept lower sweetness [53, 
54], while limiting the potential for consumers to subcon-
sciously overcompensate for perceived ‘caloric savings’ 
attained by AS usage [55]. Indeed, the American Heart 
Association and American Diabetes Association state that 
the potential benefits of AS will not be appreciated if there 
is compensatory intake of energy from other macronutri-
ent sources [56]. In an attempt to overcome the impact of 
psychological cues on EI and body weight, a double-blind 
study design was used in REFORM. However, in contrast 
to a previous study [57], the majority of participants cor-
rectly identified the regular and reformulated foods, due to 
the significant lower reported taste and palatability of the 
reformulated products. Moreover, our consumer acceptance 
findings indicate that significant improvements to the sen-
sory qualities of a selection of sugar-reduced products, that 
were included in the REFORM intervention, are necessary 
[58]. This may have influenced conscious energy compen-
sation and highlights the challenge faced by food industry 
in matching these sensory attributes in artificially sweet-
ened foods and beverages.
In conclusion, consumption of sugar-reformulated 
foods and beverages as part of a blinded dietary exchange, 
resulted in a significant reduction in sugar intake, but had 
no significant effect on body weight, BP, fasting serum 
glucose or lipid concentrations, which was in part due to 
energy balance compensation. Future work is required to 
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determine whether these findings have relevance to energy 
compensation dynamics in obese populations or fat accu-
mulation in healthy populations over a long-term dietary 
intervention period.
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